Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection

Journal of Histochemistry and Cytochemistry

Volumn 50, Issue 2, 2002, Pages 197-204

  Eicheler, Wolfgang ^a   Zips, Daniel ^a   Dörfler, Annegret ^a   Grénman, Reidar ^a   Baumann, Michael ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Exon skipping; Immunohistochemistry; Mutation; p53; Splicing; Squamous cell carcinoma

Indexed keywords

ANTIBODY; GENE PRODUCT; PROTEIN P53;

ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HEAD AND NECK CANCER; HETEROZYGOSITY; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; STOP CODON; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANIMALIA; INSERTION SEQUENCES;

EID: 0036146820     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540205000207     Document Type: Article

References (38)

1. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
2. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
3. Human p53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8
4. Quantitative evaluation of the effects of cotransplantation of heavily irradiated human tumor cells and of different immunsuppressive measures of the xenotransplantability of a human squamous cell carcinoma into athymic nude mice
5. The clinical significance of p53 aberrations in human tumours
6. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines
7. IHC vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer
8. Etablierung uns charakterisierung der strahlenempfindlichen plattenepithelkarzinom-zellinie SKX in vitro
9. Wildtype sequence of TP53, intron 7
10. The human tumour suppressor gene p53 is alternatively spliced in normal cells
11. Multiple genetic lesions in laryngeal squamous cell carcinomas
12. Alternatively-spliced p53 mRNA in the FAA-HTC1 rat hepatoma cell line without the splice site mutations
13. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
14. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
15. UT-MUC-1, a new mucoepidermoid carcinoma cell line and its radiation sensitivity
16. Alternatively splicing p53 RNA in transformed and normal cells of different tissue types
17. The 1995 Walter Hubert Lecture-molecular epidemiology of human cancer: Insights from the mutational analysis of the p53 tumour-suppressor gene
18. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers
19. Head and neck cancers
20. Simple sequence repeat polymorphism within the p53 gene
21. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
22. Multiple aberrant splicing of the p53 transcript without genomic mutations around exon-intron junctions in a case of chronic myelogenous leukaemia in blast crisis: A possible novel mechanism of p53 inactivation
23. The challenge of p53 as prognostic and predictive factor in gliomas
24. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck
25. p53 mutations, protein expression and cell proliferation in squamous cell carcinoma of the head and neck
26. Linear-quadratic analysis of tumour response to fractionated radiotherapy: A study on human squamous cell carcinoma xenografts
27. The results of colorectal cancer treatment by p53 status: A treatment-specific overview
28. The effect of irradiation on mitotic and apoptotic frequency in head and neck cancer cell lines, the correlation to p53 mutations and clonogenic survival
29. A new human cell line (FaDu) from a hypopharyngeal carcinoma
30. p53 overexpression in head and neck squamous cell carcinoma: Review of the literature
31. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines
32. Patterns of p53 gene mutations in head and neck cancer: Full-length gene sequencing and results of primary radiotherapy
33. Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer
34. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines
35. Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice
36. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: A progress report
37. Molecular assays for the diagnosis of minimal residual head-and-neck cancer: Methods, reliability, pitfalls, and solutions